Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Vasoplasmic syndrome in cardiac surgery is one of the major postoperative complications.This syndrome is characterized by persistent low blood pressure despite an optimization of preload and inotropism.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Vasoplegic syndrome | Patients suffering of vasoplegic syndrom defined by persitent arterial hypotension (MAP below70 mmHg) despite fluid rescucitation, normal or high cardiac output, and treated more than 4 hours with norepinephrine | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Post operative organ failure | every post opertaive organ failure: brain, digestive, renal, cardiac... | 30 days |
| Arrythmia | atrial fibrillation, ventricular tachycardia, ventricular flutter |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
All consecutive cardiac surgical patients who meeet inclusion criteria with cardiopulmonary bypass
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pierre Grégoire guinot.pierregregoire@chu-amiens.fr, Doctor | guinot.pierregregoire@chu-amiens.fr | Study Director |
| Paul Michel MERTES, Professor | CHU STRASBOURG | Principal Investigator |
| Jean-Luc Simon Jean-Baptiste FELLAHI, Professor | Hospices Civils de Lyon | Principal Investigator |
| FISCHER Marc Olivier, Professor | University Hospital, Caen | Principal Investigator |
| GIRARD Claude, Professor | CHU DIJON | Principal Investigator |
| Longrois Dan, Doctor | APHP, Paris | Principal Investigator |
| BESNIE Emmanuel, Doctor | University Hospital, Rouen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Amiens Picardie | Amiens | 80054 | France |
Not provided
Not provided
Not provided
Not provided
| 30 days |
| Inotropic use | dobutamine, levosimendan, phosphodiesterase | 30 days |
| cardiac damage | troponine I release | 1 day |
| Post operative Sepsis | postoperative sepsis: pneumonae, blood stream, mediastinis, urinary track, other | 30 days |
| Hemorrhage | postopertaive blood loss defined by the Universal definition of perioperative bleeding | 30 days |
| Blood transfusion | red blood cell transfusion, plaquette, plasma | 30 days |
| ICU stays | Stay at ICU until patient discharge | 30 days |
| Hospital stays | hospital stays until patient discharge | 30 days |
| Death | Death of any cause | one year |